Serum Angiogenic Profile of Patients with Glioblastoma Identifies Distinct Tumor Subtypes and Shows That TIMP-1 Is a Prognostic Factor

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neurosurgery

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1227/01.NEU.0000387045.38458.34
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.

  2024cites this paper
• High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma

  2023cites this paper
• A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases

  2023cites this paper
• The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients

  2022cites this paper
• Serum protein triplet TGF-β1, TIMP-1, and YKL-40 serve as diagnostic and prognostic profile for astrocytoma

  2021cites this paper
• The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance

  2020cites this paper
• Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.

  2019cites this paper
• Prognostic roles of high TIMP-1 expression in patients with solid tumors : a meta-analysis

  2019cites this paper
• Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma

  2019cites this paper
• Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

  2018cites this paper
• Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer

  2018cites this paper
• Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors

  2018cites this paper
• Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas

  2017cites this paper
• Molecular Mechanisms of Glioma Cell Motility

  2017cites this paper
• Identification of key genes in glioma CpG island methylator phenotype via network analysis of gene expression data

  2017cites this paper
• University of Southern Denmark Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients Aaberg-Jessen,

  2016cites this paper
• Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

  2016cites this paper
• Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer

  2015cites this paper
• Emerging circulating biomarkers in glioblastoma: promises and challenges

  2015cites this paper
• The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model

  2015cites this paper
• Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients

  2015cites this paper
• Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival

  2015cites this paper
• Liquid biopsies in patients with diffuse glioma

  2015cites this paper
• Brain tumor microarray data analyzed using clustering and novel consensus clustering techniques

  2014cites this paper
• Cutting Edge: MMP-9 Inhibits IL-23p19 Expression in Dendritic Cells by Targeting Membrane Stem Cell Factor Affecting Lung IL-17 Response

  2014cites this paper
• IL-17 Response Membrane Stem Cell Factor Affecting Lung Expression in Dendritic Cells by Targeting Cutting Edge : MMP-9 Inhibits IL-23 p 19

  2014cites this paper
• Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression

  2014cites this paper
• The Ketogenic Diet in the Treatment of Malignant Glioma: Mechanistic Effects on Hypoxia and Angiogenesis

  2014cites this paper
• Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma.

  2014cites this paper
• Towards developing biomarkers for glioblastoma multiforme: a proteomics view

  2014cites this paper
• TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression

  2013cites this paper
• Predictors of Long-Term Survival in Patients With Glioblastoma Multiforme: Advancements From the Last Quarter Century

  2013cites this paper
• Tissue Inhibitor of Metalloproteinase 1 Is Preferentially Expressed in Th1 and Th17 T-Helper Cell Subsets and Is a Direct Stat Target Gene

  2013cites this paper
• Systematic Review of Protein Biomarkers of Invasive Behavior in Glioblastoma

  2013cites this paper
• New molecularly targeted therapies for glioblastoma multiforme.

  2012cites this paper
• Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.

  2012cites this paper
• Anti-angiogenic gene therapy in the treatment of malignant gliomas.

  2012cites this paper
• Cardiotrophin-1 Promotes a High Survival Rate in Rabbits with Lethal Fulminant Hepatitis of Viral Origin

  2011cites this paper